In hepatoblastoma cells, increased METTL3 activity resulted in increased m6A deposition on Ctnnb1, leading to aberrant activation of the WNT/CTNNB1 pathway, which promoted hepatoblastoma cell growth (Liu et al., 2019). Here, METTL3 is linked to hepatoblastoma.